Can the House GOP's truce last?

Presented by The Campaign for Sustainable Rx Pricing: An evening recap of the action on Capitol Hill and preview of the day ahead
Nov 15, 2024 View in browser
 
POLITICO Newsletter Header

By Jordain Carney

Presented by The Campaign for Sustainable Rx Pricing

With assists from POLITICO’s Congress team

Speaker of the House Mike Johnson speaks at a press conference.

Some of Johnson’s most vocal critics weren’t part of the negotiating team that locked in the rules agreement. | Angelina Katsanis/POLITICO

WHY CAN’T WE BE FRIENDS?

House Republicans emerged from two days of closed-door meetings this week declaring a truce on some of their biggest internal sticking points and preaching unity heading into January’s GOP trifecta in Washington.

But that doesn’t mean House Republicans, or Speaker Mike Johnson, are on a smooth path going into next year — a fact GOP lawmakers acknowledged even as they managed to defuse the first round of their rules fight.

Most notably, conservatives agreed to raise the threshold on forcing a vote to oust a speaker to nine members and centrists dropped their push for punitive actions against Republicans who defied leadership’s wishes. The former would be a critical change in the new Congress, but only if it’s ultimately approved in January as part of the House rules package.

When asked about raising the threshold to boot a speaker, known as the motion to vacate, up from just one member, Rep. Chip Roy (R-Texas) responded: “That has to be voted on. That’s the spirit of the agreement and, to be clear, I’m not walking that back or anything, I’m just saying there are people who agreed to that, there are people who didn’t.”

Notably, some of Johnson’s most vocal critics weren’t part of the negotiating team that locked in the rules agreement.

We got a further taste of possible hurdles ahead this week, when that last-minute rules agreement appeared to be on the brink of unraveling after Rep. Bill Huizenga (R-Mich.) said he hadn’t agreed to drop his amendments. He had proposed two that would have punished members for opposing a conference-blessed speaker nominee or blocking GOP legislative priorities.

One member, granted anonymity to speak candidly, told us the deal was meant to “force team play.” But they sidestepped when asked if they thought it would stick, deferring to negotiators. (They also recounted being confused when Huizenga approached them — while the lawmaker was working out — to talk about the rules drama on Thursday morning.)

In the end, Rep. Dusty Johnson (R-S.D.) and other Main Street Caucus members got Huizenga on board. But it’s a reminder that, with the House GOP’s narrow majority, Johnson has to have a full lock on almost his entire conference — a group full of members who see themselves as independent actors.

“Yeah we’re going to run into some speed bumps, but if we don’t get rid of the motion to vacate at one, we are totally going to run into a brick wall, without question,” said Rep. Max Miller (R-Ohio).

Even as conservatives helped negotiate the rules deal they aren’t yet committing to actually voting for Johnson during the speaker's race, set to start on Jan. 3. They want to see how a coming spending debate plays out, especially.

“We still have to get through December, you know, we’ve got to see how negotiations go in the lame duck. … All of this adds up to, how are decisions going to be made? What is the organization of the House?” Roy said.

– Jordain Carney

GOOD EVENING! Welcome to Inside Congress, the play-by-play guide to all things Capitol Hill, on this Friday, Nov. 15, where there are major TGIF feelings around the building (incoming members excluded).

 

A message from The Campaign for Sustainable Rx Pricing:

Big Pharma games the system to keep prescription drug prices high. Brand name drug companies build blockades of patents to extend monopolies and block competition from more affordable alternatives – costing patients, taxpayers and the U.S. health care system billions of dollars each year. Market-based solutions to hold Big Pharma accountable for their egregious anti-competitive tactics, especially patent thickets, have broad bipartisan support. Congress must pass these solutions into law. Learn more.

 

ETHICS RULES CHECK-IN

POLITICO’s Congress team brought you the latest on the House Ethics panel’s no-win situation over the Gaetz report. And while we know everyone is acting like a congressional ethics expert this week, we decided to talk to some actual pros.

The Ethics Committee commonly opts against releasing reports on lawmakers who have resigned from the House, even when it’s clear the resignation is intended to keep the report from becoming public.

But that’s not a House or Ethics Committee rule. It’s not even a solid precedent. Committee members say their jurisdiction ends as soon as the resignation is processed. And yes, their jurisdiction for punishment ended — but they get to decide what to do with the information collected in the probe.

“Jurisdiction does not affect the ability to release this report,” Kedrick Payne, former deputy chief counsel of the Office of Congressional Ethics, told Inside Congress. Payne currently serves as the Campaign Legal Center’s general counsel and senior director of ethics.

The Ethics panel has released reports on lawmakers who resigned at least twice in history — though not recently. The committee voted in 1987 to publish its report on former Rep. William Boner (D-Tenn.) after he resigned from the House, and did the same for Rep. Donald Lukens (R-Ohio) in 1990. More recently, the Office of Congressional Ethics has released reports when the Ethics Committee opted not to.

“If there was a willingness to do it, I think absolutely there's no doubt they could,” said Meredith McGehee, an independent expert in government ethics. “So now we’re just back to a political question.”

After first saying he wouldn’t weigh in on the committee’s business, Johnson called on the Ethics panel to not release the report. The speaker said not releasing reports is both a “very important rule” and “the House’s tradition.” In reality, it’s a courtesy members of the Ethics Committee can decide to grant on a case-by-case basis.

“If it's been broken once or twice, it should not have been, because that would be a Pandora's box. I think it's a very important tradition to maintain,” Johnson told reporters Friday.

Keep in mind: Even if the Ethics panel doesn’t want to make the report public, they can vote to share it with the Senate Judiciary Committee as vetting begins ahead of confirmation hearings. But the chance of leaks increases the moment it leaves the committee’s tight grip.

Speaking of the Senate: “I do think it’s hilarious that senators are demanding anything of the House Ethics Committee. Maybe they should take their own Ethics Committee out of mothballs before they make demands,” Rep. Kelly Armstrong (R-N.D.) said Friday of the notoriously inactive Senate panel. “They had a guy with gold bars in his shoes and couldn’t manage to start an inquiry.”

— Katherine Tully-McManus with a hand from Jordain Carney and Olivia Beavers

 

A message from The Campaign for Sustainable Rx Pricing:

Advertisement Image

 

ANOTHER GOP LEADERSHIP ELECTION 

Rep. August Pfluger (R-Texas) won the race to chair the Republican Study Committee, defeating Rep. Ben Cline (R-Va.) in a 80-57 vote behind closed doors on Friday morning.

Pfluger is succeeding Rep. Kevin Hern (R-Okla.), who defeated Rep. Gary Palmer (R-Ala.) earlier this week in the race to become the House GOP’s policy chair.

The RSC is the largest official faction within the House GOP conference, including centrists, moderates, more traditional conservatives and even some members of the ultra-conservative Freedom Caucus. Speaker Mike Johnson previously led the group.

Winning the RSC gavel will give Pfluger a seat in weekly meetings Johnson holds with members of leadership, heads of the respective “families” within the House GOP conference and other members. And he’ll have a higher perch within the overall conference as Republicans try to deliver with their slim margins in the new Washington Republican trifecta.

“The RSC will continue to be the conservative backbone of the House, pushing for a strong, resilient America that can stand up to both foreign adversaries and domestic challenges,” Pfluger said in a statement after his win.

— Jordain Carney, with an assist from Olivia Beavers 

 

REGISTER NOW: Join POLITICO and Capital One for a deep-dive discussion with Acting HUD Secretary Adrianne Todman, Rep. Darin LaHood (R-IL), Rep. Ritchie Torres (D-NY) and other housing experts on how to fix America’s housing crisis and build a foundation for financial prosperity. Register to attend in-person or virtually here.

 
 
HUDDLE HOTDISH

Jasmine Crockett officially jumped into a leadership race against Debbie Dingell.

Shout out to Rep. Derek Kilmer (D-Wash.), who tried to say hi to us today, but we could only think of his obsession with the fate of Congress that always reminds us of a certain Barbie gif.

No one has enthusiasm for a windowless room like incoming freshman senators getting to work at Lumon/their temporary basement offices.

Rep. Dan Crenshaw (R-Texas) is urging Speaker Mike Johnson to create a select committee next year “to defeat the Mexican drug cartels.”

 

Policy change is coming—be the pro who saw it first. Access POLITICO Pro's Issue Analysis series on what the transition means for agriculture, defense, health care, tech, and more. Strengthen your strategy.

 
 

QUICK LINKS 

Thune faces first Trump loyalty test, from Anthony, KTM and Ursula

New Jersey Rep. Josh Gottheimer launches campaign for governor, by Matt Friedman

New York Republicans now have an Elise Stefanik-sized void to fill, from Emily Ngo

Congress expects White House disaster aid request next week covering hurricane damage, from Jennifer Scholtes

TRANSITIONS 

Elections mean major shakeups. Send us your next steps to insidecongress@politico.com!

 

A message from The Campaign for Sustainable Rx Pricing:

Big Pharma's abuse of the patent system is designed to maintain monopolies over their biggest money-makers, boosting brand name drug makers’ profits at the expense of American patients and taxpayers. One of their anti-competitive tactics involves filing dozens, sometimes hundreds, of patents on blockbuster products to build extensive “patent thickets,” completely disconnected from any true innovation. An economic analysis found Big Pharma’s patent thickets on just five drugs cost American patients and the U.S. health care system more than $16 billion in a single year.

The Congressional Budget Office has confirmed bipartisan, market-based solutions to hold Big Pharma accountable for patent abuse will lower drug prices and the U.S. Senate unanimously passed one solution, Cornyn-Blumenthal (S.150), earlier this year. Now is the time for Congress to finish the job – and pass solutions to lower drug prices by cracking down on patent abuse and promoting competition. Learn more.

 

MONDAY IN CONGRESS

The House will hold votes at 6:30 p.m.

The Senate will vote at 5:30 p.m.

MONDAY AROUND THE HILL

The House Rules Committee will meet at 4 p.m.

TRIVIA

THURSDAY’S ANSWER: Bob Koczera correctly answered that John Rutledge and Earl Warren were the chief justices of the Supreme Court who were initially recess appointed.

TODAY’S QUESTION, from Bob: Who was the first sitting associate justice to be elevated to the position of chief justice?

The first person to correctly guess gets a mention in the next edition of Inside Congress. Send your answers to insidecongress@politico.com.

GET INSIDE CONGRESS emailed to your phone each evening.

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://login.politico.com/?redirect=https%3A%2F%2Fwww.politico.com/settings

This email was sent to salenamartine360.news1@blogger.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Unsubscribe | Privacy Policy | Terms of Service

Post a Comment

Previous Post Next Post